108
Views
4
CrossRef citations to date
0
Altmetric
Original Research

L-carnitine supplementation in patients with HIV/AIDS and fatigue: a double-blind, placebo-controlled pilot study

, , , , &
Pages 65-73 | Published online: 19 Feb 2015

References

  • SchifittoGDengLYehTMClinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individualsJ Neurovirol201117172521181521
  • SilvérioRLavianoARossi FanelliFSeelaenderML-carnitine and cancer cachexia: clinical and experimental aspectsJ Cachexia Sarcopenia Muscle20112374421475677
  • BonaféLBergerMMQueYAMechanickJICarnitine deficiency in chronic critical illnessCurr Opin Clin Nutr Metab Care20141720020924500444
  • CrucianiRADvorkinEHomelPL-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysisAnn N Y Acad Sci2004103316817615591014
  • YangSKXiaoLSongPAXuXLiuFYSunLEffect of L-carnitine therapy on patients in maintenance hemodialysis: a systematic review and meta-analysisJ Nephrol20142731732924535997
  • Esteban-CrucianiNVSevere carnitine deficiency in children with AIDS: improved functional activity status after supplementationPediatr Res200149254A
  • De SimoneCTzantzoglouSJirilloEMarzoAVulloVMartelliEAL-carnitine deficiency in AIDS patientsAIDS199262032051558717
  • YatesJWChalmerBMcKegneyFPEvaluation of patients with advanced cancer using the Karnofsky Performance StatusCancer198040222022247370963
  • Quest Diagnostics [webpage on the Internet] Available from http://www.questdiagnostics.com/testcenter/BUOrderInfo.action?tc=70107X&labCode=SJCAccessed 23 December 2014
  • BelayBEsteban-CrucianiNWalshCAKaskelFJThe use of levo-carnitine in children with renal disease: a review and a call for future studiesPediatr Nephrol20062130831716374652
  • MendozaTRWangXSCleelandCSThe rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue InventoryCancer1999851186119610091805
  • McCorkleRYoungKDevelopment of a symptom distress scaleCancer Nurs19781373378250445
  • YellenSBCellaDFWebsterKBlendowskiCKaplanEMeasuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement systemJ Pain Symptom Manage19971363749095563
  • FolsteinMFFolsteinSEMcHughPR“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res1975121891981202204
  • ChangVTHwangSSFeuermanMKasimisBSThalerHTThe Memorial Symptom Assessment Scale Short Form (MSAS-SF)Cancer2000891162117110964347
  • RadloffLSThe CES-D scale: a self-report depression scale for research in the general populationAppl Psychol Meas19771385401
  • GrazianoFBisonniRCatalanoVPotential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anemic cancer patientsBr J Cancer2002861854185712085175
  • CrucianiRADvorkinEHomelPL-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled studyJ Pain Symptom Manage20093762263118809275
  • HedekerDGibbonsRDApplication of random-effects pattern-mixture models for missing data in longitudinal studiesPsychol Methods199726478
  • MalaguarneraMGarganteMPCristaldiEAcetyl-L-carnitine treatment in minimal hepatic encephalopathyDig Dis Sci2008533018302518357530
  • MalaguarneraMVacanteMGiordanoML-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirinWorld J Gastroenterol2011174414442022110268
  • MalaguarneraMCammalleriLGarganteMPVacanteMColonnaVMottaML-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trialAm J Clin Nutr2007861738174418065594
  • CrucianiRAZhangJJManolaJCellaDAnsariBFischMJL-carnitine supplementation for the management of fatigue in patients with cancer: an Eastern Cooperative Oncology Group Phase III, randomized, double-blind, placebo-controlled trialJ Clin Oncol2012303864386922987089
  • HershmanDLUngerJMCrewKDRandomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapyJ Clin Oncol2013312627263323733756
  • MorettiSAlesseEDi MarzioLEffect of L-carnitine on human immunodeficiency virus-1 infection-associated apoptosis: a pilot studyBlood19981591 :3817–3824.
  • MantovaniGMacciòAMadedduCRandomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexiaOncologist20101520021120156909
  • ClaessensYEChicheJDMiraJPCariouABench to bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitorsCrit Care2003722623212793872
  • DlaminiJLedwabaLMokwenaNLactic acidosis and symptomatic hyperlactataemia in a randomized trial of first-line therapy in HIV-infected adults in South AfricaAntivir Ther20111660560921685549
  • RidruejoESilvaMOSafety of long-term nucleos(t)ide treatment in chronic hepatitis BExpert Opin Drug Saf20121135736022417072
  • FoutyBFrermanFRevesRRiboflavin to treat nucleoside analogues induced lactic acidosisLancet19983522912929690419
  • ClaessensYECariouAMonchiMDetecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with L-carnitineCrit Care Med2002311042104712682470